Minaris Advanced Therapies Opens New State-of-the-Art GMP Facility to Support Global Cell and Gene Therapy Growth

Minaris Advanced Therapies opens new manufacturing facility in Germany

The new facility will help Minaris support its worldwide cell and gene therapy growth. It is designed to facilitate the technology transfer of commercial advanced therapies into Europe. The post Minaris Advanced Therapies opens new manufacturing facility in Germany appeared first on Pharmaceutical Business review.

Minaris Advanced Therapies launches new manufacturing facility in Munich

Minaris’ new facility builds on over ten years of experience in both the clinical and commercial manufacturing of advanced therapies.The post Minaris Advanced Therapies launches new manufacturing facility in Munich appeared first on Investment Monitor.

Minaris Advanced Therapies Opens New State-of-the-Art GMP Facility to Support Global Cell and Gene Therapy Growth

MUNICH, Aug. 4, 2025 /PRNewswire/ — Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany.  The facility, located in Taufkirchen, strengthens Minaris’ global manufacturing network and reinforces its position as a trusted partner in advancing cutting-edge therapies […] The post Minaris Advanced Therap…